Skip to main content
. 2022 May 3;13:884931. doi: 10.3389/fimmu.2022.884931

Table 2.

Concomitant therapy during each rituximab cycle with patient outcomes.

Cycle No. patients No. patients receiving concomitant steroid dose Mean concomitant steroid dose per day No. patients receiving adjuvant* No. patients in CROT No. patients in CRMT Relapsed
1st 19 19/19 (100%) 31 mg 16/19 (84.2%) 2/19 (10.5%) 6/19 (31.5%) 44.4%
2nd 7 7/7
(100%)
21 mg 4/7
(57.1%)
1/7 (14.3%) 6/7 (85.7%) 42.8%
3rd 3 3/3
(100%)
16 mg 1/3
(33.3%)
0/3 3/3 (100%) 0%

*Azathioprine 100 mg/day.